Regionally, the global intranasal corticosteroids market is studied into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Asia Pacific industry is predicted to account for largest revenue share by 2037, on account of higher prevalence of type 1 diabetes, rheumatoid arthritis, and other types of scleros. China and India are the countries with a skyrocketing prevalence of type 1 diabetes since half of the total diabetes patients in the Asia Pacific are living in these two countries. Based on the data provided by the International Diabetes Federation in 2021, it was stated that 90 million people have diabetes in South-East Asia while the figure is further expected to reach 152 million over the forecast period. Hence, the market is anticipated to grow at a significant pace over the forecast period in the Asia Pacific Region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?